期刊文献+

不同促排卵方案对多囊卵巢综合征不孕症患者治疗效果的临床研究 被引量:8

Clinical study on the therapeutic effect of different ovulation induction regimens on infertility patients with polycystic ovary syndrome
在线阅读 下载PDF
导出
摘要 目的研究不同促排卵方案对多囊卵巢综合征(PCOS)不孕症患者的治疗效果。方法选取我院自2017年1月~2019年1月收治的90例PCOS不孕症患者,按随机数字表法分为两组,每组45例。对照组给予克罗米芬(CC)促排卵方案治疗,观察组给予CC联合来曲唑(LE)促排卵方案治疗,治疗周期中,如无优势卵泡发育、肌注尿促性素(HMG)。比较两组患者的促排卵效果、子宫内膜与卵泡发育情况及妊娠结局。结果观察组的诱排时间短于对照组,HMG用量少于对照组,排卵率高于对照组(P<0.05);观察组子宫内膜厚度大于对照组,成熟卵泡个数少于对照组(P<0.05),两组最大卵泡直径比较,差异无统计学意义(P>0.05);观察组临床妊娠率高于对照组(P<0.05),两组流产、多胎妊娠、OHSS发生率比较,差异均无统计学意义(P>0.05)。结论相较于CC单独促排卵,CC联合LE促排卵方案治疗PCOS不孕症可明显缩短诱排时间,减少HMG用量,提高排卵率与妊娠率,改善妊娠结局。 Objective To study the therapeutic effect of different ovulation induction regimens on infertility patients with polycystic ovary syndrome(PCOS). Methods 90 patients with PCOS infertility admitted to our hospital from January2017 to January 2019 were divided into two groups according to random number table method, with 45 cases in each group. The control group was treated with clomiphene citrate(CC) ovulation induction therapy, and the observation group was given CC combined with letrozole(LE) ovulation induction therapy. During the treatment cycle, if there was no dominant follicular development, the patients were given intramuscular injection of rinary human menopausal gonadotropin(HMG). The effect of ovulation induction, endometrial and follicular development, and pregnancy outcome were compared between the two groups. Results The induction time of the observation group was shorter than that of the control group. The dose of HMG was lower than that of the control group, and the ovulation rate was higher than that of the control group(P<0.05). The endometrial thickness of the observation group was larger than that of the control group, and the number of mature follicles was less than that of the control group(P<0.05). There was no significant difference in the maximum follicle diameter between the two groups(P>0.05). The clinical pregnancy rate of the observation group was higher than that of the control group(P<0.05). There was no significant difference in the incidence of abortion, mul tiple pregnancy and OHSS between two groups(P>0.05). Conclusion Compared to CC ovulation induction alone, CC combined with LE ovulation induction therapy for PCOS infertility can significantly shorten the time of induction, reduce the dose of HMG, increase the rate of ovulation and pregnancy rate, and improve the pregnancy outcome.
作者 张靖 ZHANG Jing(Department of Obstetrics and Gynecology,Jiamusi Maternal and Child Health Hospital in Heilongjiang Province,Jiamusi 154002,China)
出处 《中国现代医生》 2020年第9期82-84,89,共4页 China Modern Doctor
关键词 克罗米芬 来曲唑 多囊卵巢综合征不孕症 妊娠结局 Clomiphene citrate Letrozole Polycystic ovary syndrome infertility Pregnancy outcome
  • 相关文献

参考文献14

二级参考文献121

  • 1许良智,张静.多囊卵巢综合征[J].现代临床医学,2006,32(4):311-314. 被引量:10
  • 2李莉,章汉旺.芳香酶抑制剂——来曲唑促排卵作用的研究进展[J].生殖与避孕,2006,26(8):486-490. 被引量:17
  • 3黎平,阮晓红,郭江华,陈晓燕,邓爱民.来曲唑与克罗米芬诱导排卵疗效比较[J].中国医药,2007,2(6):364-366. 被引量:6
  • 4苏继莲,艾红,郑建淮,夏燕.来曲唑联合氯米芬对PCOS患者子宫卵巢血流动力学影响[J].实用妇产科杂志,2007,23(6):348-350. 被引量:7
  • 5ZawadsjuJK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach[M]. In: Dunaif A, GivenJR, Haseltine FP, eds. Polycystic ovary syndrome. Boston ( MA ) : Blackwell Scientific Publication, 1992,377-384.
  • 6Rotterdam ESHREI ASRM -Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome ( PCOS)[J]. Hum Reprod, 2004,19 :4147.
  • 7Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline[J].J Clin Endocrinol Metab, 2006, 91 :42374245.
  • 8Azziz R, Carmina E, Dewailly D, et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of the Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertil Steril, 2009,91 :456488.
  • 9Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients[J].J Clin Endocrinol Metab, 2004,89:453462.
  • 10Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome[J]. Dermatol Ther, 2006,19:210-223.

共引文献408

同被引文献81

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部